GENEREX BIOTECHNOLOGY CORP 4
4 · GENEREX BIOTECHNOLOGY CORP · Filed Jun 20, 2013
Insider Transaction Report
Form 4
FELLOWS STEPHEN
Acting CFO
Transactions
- Sale
Common Stock
2013-06-18$0.04/sh−2,524,164$89,608→ 0 total
Footnotes (1)
- [F1]The shares sold were acquired by the reporting person on June 6, 2013 upon exercise of options to purchase 2,524,164 shares of the issuer's common stock which were granted by the Board of Directors on March 5, 2013 and June 4, 2013 in lieu of cash payment of deferred compensation. The option grants were effective upon the reporting person's execution of Settlement and Release Agreements with the issuer on April 1, 2013 and June 6, 2013, respectively. The option grants were made pursuant to the terms of the issuer's 2006 stock plan.